Citation: Ej. Estlin et S. Ablett, Practicalities and ethics of running clinical trials in paediatric oncology - the UK experience, EUR J CANC, 37(11), 2001, pp. 1394-1398
Authors:
Veal, GJ
Griffin, MJ
Price, E
Parry, A
Dick, GS
Little, MA
Yule, SM
Morland, B
Estlin, EJ
Hale, JP
Pearson, ADJ
Welbank, H
Boddy, AV
Citation: Gj. Veal et al., A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin, BR J CANC, 84(8), 2001, pp. 1029-1035
Authors:
Estlin, EJ
Pinkerton, CR
Lewis, IJ
Lashford, L
McDowell, H
Morland, B
Kohler, J
Newell, DR
Boddy, AV
Taylor, GA
Price, L
Ablett, S
Hobson, R
Pitsiladis, M
Brampton, M
Clendeninn, N
Johnston, A
Pearson, ADJ
Citation: Ej. Estlin et al., A phase I study of nolatrexed dihydrochloride in children with advanced cancer. A United Kingdom Children's Cancer Study Group Investigation, BR J CANC, 84(1), 2001, pp. 11-18
Authors:
Estlin, EJ
Cotterill, S
Pratt, CB
Pearson, ADJ
Bernstein, M
Citation: Ej. Estlin et al., Phase I trials in pediatric oncology: Perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology Group, J CL ONCOL, 18(9), 2000, pp. 1900-1905
Citation: Ej. Estlin et al., The clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase, anthracyclines and cyclophosphamide in relation to childhood acute lymphoblastic leukaemia, BR J HAEM, 110(4), 2000, pp. 780-790
Citation: Ej. Estlin et al., Optimizing antimetabolite-based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia, BR J HAEM, 110(1), 2000, pp. 29-40
Authors:
Barnes, MJ
Estlin, EJ
Taylor, GA
Aherne, GW
Hardcastle, A
McGuire, JJ
Calvete, JA
Lunec, J
Pearson, ADJ
Newell, DR
Citation: Mj. Barnes et al., Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines, CLIN CANC R, 5(9), 1999, pp. 2548-2558
Citation: Gaa. Burke et al., The role of pharmacokinetic and pharmacodynamic studies in the planning ofprotocols for the treatment of childhood cancer, CANC TR REV, 25(1), 1999, pp. 13-27